0
Skip to Content
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Alliance for a Stronger FDA
About Us
Leadership
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Folder: About
Back
About Us
Leadership
Folder: Members
Back
Join Us
List of Members
Who can Become a Member
Dues Structure
Budget Docs
Contact
Alliance Archives
Join Us
Advocacy at a Glance Guest User 5/1/20 Advocacy at a Glance Guest User 5/1/20

Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent

Read More
Advocacy at a Glance Guest User 1/17/20 Advocacy at a Glance Guest User 1/17/20

The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington

Read More
Analysis and Commentary Guest User 12/20/19 Analysis and Commentary Guest User 12/20/19

Success Again in 2019 ... Building Support for 2020

Read More
Advocacy at a Glance Guest User 12/20/19 Advocacy at a Glance Guest User 12/20/19

FY 20 Appropriations: Headed to the President for His Signature

Read More
Analysis and Commentary Guest User 12/16/19 Analysis and Commentary Guest User 12/16/19

FDA's "Appropriation Fate" Is Evaluated on a Daily Basis

Read More
Advocacy at a Glance Guest User 12/16/19 Advocacy at a Glance Guest User 12/16/19

Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday

Read More
Analysis and Commentary Guest User 12/8/19 Analysis and Commentary Guest User 12/8/19

Three Key Questions ... and the Answers

Read More
Advocacy at a Glance Guest User 12/8/19 Advocacy at a Glance Guest User 12/8/19

The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems

Read More
Advocacy at a Glance Guest User 11/22/19 Advocacy at a Glance Guest User 11/22/19

Continuing Resolution Extends Funding through December 20

Read More
Analysis and Commentary Guest User 11/15/19 Analysis and Commentary Guest User 11/15/19

FY 20 Appropriations: More Qs; More As

Read More
Advocacy at a Glance Guest User 11/15/19 Advocacy at a Glance Guest User 11/15/19

Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close

Read More
Analysis and Commentary Guest User 11/11/19 Analysis and Commentary Guest User 11/11/19

FY 20 Appropriations: How, When, and Why?

Read More
Advocacy at a Glance Guest User 11/11/19 Advocacy at a Glance Guest User 11/11/19

A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December

Read More
Advocacy at a Glance Guest User 11/1/19 Advocacy at a Glance Guest User 11/1/19

Senate Passes First Minibus, Which Includes Ag/FDA Funding

Read More
Analysis and Commentary Guest User 10/25/19 Analysis and Commentary Guest User 10/25/19

Establishing Order: The Chickens and the Eggs

Read More
Advocacy at a Glance Guest User 10/25/19 Advocacy at a Glance Guest User 10/25/19

Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week

Read More
Analysis and Commentary Guest User 10/5/19 Analysis and Commentary Guest User 10/5/19

Full-Year CR: Better Than a Shutdown, But ...

Read More
Advocacy at a Glance Guest User 10/5/19 Advocacy at a Glance Guest User 10/5/19

FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR

Read More
Analysis and Commentary Guest User 9/30/19 Analysis and Commentary Guest User 9/30/19

"Wouldn't It Be Wonderful"

Read More
Advocacy at a Glance Guest User 9/30/19 Advocacy at a Glance Guest User 9/30/19

President to Sign CR; Government Will Stay Open to November 21

Read More
Older Posts

The Alliance for a Stronger FDA | 918 14th Street, SE, Apt 1 Washington, DC 20003 | cartier@strengthenfda.org | LinkedIn

The Alliance for a Stronger FDA is an independent, not-for-profit 501(c)(4) corporation registered in the state of Maryland. It is not affiliated with the FDA and current FDA employees can not become members of the Alliance. For information from the FDA, please click here. Copyright 2025, Alliance for a Stronger FDA.